GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (OTCPK:CNADF) » Definitions » EV-to-Revenue

CanadaBis Capital (CanadaBis Capital) EV-to-Revenue : 0.72 (As of Jun. 08, 2024)


View and export this data going back to 2023. Start your Free Trial

What is CanadaBis Capital EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, CanadaBis Capital's enterprise value is $11.18 Mil. CanadaBis Capital's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 was $15.52 Mil. Therefore, CanadaBis Capital's EV-to-Revenue for today is 0.72.

The historical rank and industry rank for CanadaBis Capital's EV-to-Revenue or its related term are showing as below:

CNADF' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.67   Med: 1.89   Max: 104.62
Current: 0.73

During the past 8 years, the highest EV-to-Revenue of CanadaBis Capital was 104.62. The lowest was 0.67. And the median was 1.89.

CNADF's EV-to-Revenue is ranked better than
86.18% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 2.275 vs CNADF: 0.73

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-08), CanadaBis Capital's stock price is $0.0573. CanadaBis Capital's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 was $0.11. Therefore, CanadaBis Capital's PS Ratio for today is 0.51.


CanadaBis Capital EV-to-Revenue Historical Data

The historical data trend for CanadaBis Capital's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital EV-to-Revenue Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23
EV-to-Revenue
Get a 7-Day Free Trial - 7.31 3.69 1.08 1.99

CanadaBis Capital Quarterly Data
Mar19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 1.85 1.99 1.60 1.73

Competitive Comparison of CanadaBis Capital's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanadaBis Capital's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's EV-to-Revenue falls into.



CanadaBis Capital EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

CanadaBis Capital's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=11.177/15.522
=0.72

CanadaBis Capital's current Enterprise Value is $11.18 Mil.
CanadaBis Capital's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $15.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanadaBis Capital  (OTCPK:CNADF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

CanadaBis Capital's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0573/0.112
=0.51

CanadaBis Capital's share price for today is $0.0573.
CanadaBis Capital's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.11.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanadaBis Capital EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CanadaBis Capital (CanadaBis Capital) Business Description

Traded in Other Exchanges
Address
PO Box 850, Rocky Mountain House, AB, CAN, T4T 1A6
CanadaBis Capital Inc is a vertically-integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premise owned and operated by the Company. Extraction and tolling segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.